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Abstract
Vascular cognitive impairment is the second most common form of dementia. The pathogenic pathways leading to
vascular cognitive impairment remain unclear but clinical and experimental data have shown that chronic reactive
astrogliosis occurs within white matter lesions, indicating that a sustained pro-inflammatory environment affecting
the white matter may contribute towards disease progression. To model vascular cognitive impairment, we induced
prolonged mild cerebral hypoperfusion in mice by bilateral common carotid artery stenosis. This chronic hypoperfusion
resulted in reactive gliosis of astrocytes and microglia within white matter tracts, demyelination and axonal degeneration,
consecutive spatial memory deficits, and loss of white matter integrity, as measured by ultra high-field magnetic
resonance diffusion tensor imaging. White matter astrogliosis was accompanied by activation of the pro-inflammatory
transcription factor nuclear factor (NF)-kB in reactive astrocytes. Using mice expressing a dominant negative inhibitor of
NF-kB under the control of the astrocyte-specific glial fibrillary acid protein (GFAP) promoter (GFAP-IkBα-dn), we found
that transgenic inhibition of astroglial NF-kB signaling ameliorated gliosis and axonal loss, maintained white matter
structural integrity, and preserved memory function. Collectively, our results imply that pro-inflammatory changes
in white matter astrocytes may represent an important detrimental component in the pathogenesis of vascular
cognitive impairment, and that targeting these pathways may lead to novel therapeutic strategies.
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Introduction
Vascular cognitive impairment (VCI) is a common neu-
rodegenerative disease characterised by impaired cogni-
tive function attributable to cerebrovascular pathology
[1]. In its pure form, VCI is the second most common
form of dementia and represents an important co-factor
for the development of Alzheimer’s disease and other
neurodegenerative disorders [2]. Neuropathologically,
VCI is characterised by demyelination and axonal loss
within white matter tracts [3], which has traditionally
been attributed to the direct effects of chronic oxygen
deprivation. However, several lines of evidence suggest
that chronic neuroinflammation may also play a detrimen-
tal role in the initiation and progression of VCI. First,
cerebrovascular and cardiovascular diseases, which are
risk factors for VCI, induce a chronic pro-inflammatory
environment, particularly in and around blood vessels
[4, 5]. Second, increased levels of pro-inflammatory
markers have been detected within white matter lesions
in animal models and post-mortem studies of VCI
patients [6, 7], and alterations of blood–brain barrier in-
tegrity are a central and perhaps aggravating element of
VCI [8, 9]. Finally, in patients and animal models of VCI,
reactive gliosis of microglia and astrocytes is present
within the white matter [10, 11]. Reactive astrogliosis is
a pervasive defence mechanism in response to cerebral
injury that may promote neurodegeneration or neuropro-
tection in a context-dependent manner [12]. However,
the roles of astrogliosis and the various inflammatory
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cascades mediated by reactive astrocytes in chronic cere-
bral hypoperfusion and VCI remain poorly understood.
Here, we have used an animal model that recapitulates
many of the neuropathological and behavioural hallmarks
of VCI [13]. We demonstrate that reactive astrogliosis
induces activation of the pro-inflammatory nuclear fac-
tor (NF)-kB pathway in astrocytes, and that transgenic
inhibition of this pathway confers protection against
axonal loss, helps to promote white matter integrity,
and preserves cognitive function.
Materials and methods
Animals
All experiments were approved by a local animal welfare
committee. We used 10–14 week-old male GFAP-IkBα-
dn mice [14] and their wildtype age-matched male litter-
mates. Animals were housed in groups (two to five per
cage) on a 12 h light/dark cycle with food and water
available ad libitum.
Chronic hypoperfusion model
Gold plated stainless steel microcoils (Sawane) were
wrapped around both common carotid arteries in
isoflurane-anaesthetised mice [13]. Informed by earlier
studies that revealed either subtle [15, 16] or very pro-
nounced changes [17], we modified the existing model
by using custom-made coils with an internal diameter of
170 μm. Animals were anaesthetised with isoflurane
(1.5 % v/v) and maintained on a heating pad (37 °C).
The common carotid arteries were exposed through a
midline cervical incision, and the microcoils were
wrapped around both common carotid arteries. A
30 min interval was allowed between each microcoil
insertion. Sham-treated animals underwent identical
procedures except that coils were not implanted. Local
lidocaine gel and intraperitoneal buprenorphine were
applied as analgesics. Mice from each litter were rando-
mised to either microcoil insertion or sham surgery. All
experiments and subsequent data analysis were con-
ducted in a blinded manner, with respect to genotype
and treatment. Mice were excluded if visual damage to
the carotid arteries or bleeding during surgery occurred.
In addition, carotid arteries were inspected for patency at
the end of experiments, and animals with occluded carotid
arteries were also excluded.
Laser speckle perfusion imaging and PcomA assessment
Animals were anaesthetised with isoflurane (1.5 % v/v),
and the skull was exposed through a midline incision. A
cranial window was created and closed by gluing a glass
coverslip onto the skull and adhering the skin to the
coverslip rim. For imaging, mice were anaesthetised with
isoflurane (1 % v/v) and fixed within a stereotaxic frame
(Narishige). Brain perfusion was determined through
a closed cranial window in anaesthetised mice using
PeriCam PSI Laser Speckle Imager and PIMsoft soft-
ware (Perimed). PcomA development was determined
by transcardial perfusion with India ink (Pelikan; 10 %
in water containing 10 % gelatine), followed by decapi-
tation and fixation in 4 % paraformaldehype (PFA).
PcomA was scored as: 0, absent; 1, hypoplastic; 2, trun-
cal. A single PcomA score was calculated by averaging
left and right scores.
Ultra high-field MRI
MRI of isoflurane-anaesthetised mice was performed on
an 11.7 T horizontal small-bore magnet (Biospec 117/16,
Bruker) using a two-element transmit/receive proton
(1H) cryocoil (Bruker Biospin). Body temperature was
maintained at 37 °C via an integrated water heating sys-
tem. Respiratory rate was maintained at 70-80 cycles/min.
Anatomical images were acquired using a rapid acqui-
sition relaxation enhancement (RARE) T2-weighted
(T2-w) sequence [echo time (TE) = 0.01 s; repetition
time (TR) = 2.5 s; in-plane resolution 45 μm2], and a
RARE T1-weighted (T1-w) sequence (TE/TR = 0.01 s/1 s;
in-plane resolution 45 μm2). White matter integrity was
assessed using an EPI DTI sequence (TE/TR 26/4000 ms;
b value 1000 s/mm2; 60 diffusion directions; 5 b0 images;
in-plane resolution 100 μm2).
Immunohistochemistry
Coronal sections (20 μm) were obtained from PFA-fixed
hemispheres, blocked with 10 % normal goat serum
(Vector Labs) and 0.3 % Triton-X100 (Sigma) in PBS for
1 h, and incubated with primary antibodies in PBS con-
taining 5 % goat serum and 0.05 % Triton overnight at
4 °C. The following primary antibodies were used: rabbit
anti-GFAP (1:1000; Z0334, Dako), rat anti-GFAP (1:1000;
13-0300, Invitrogen), rabbit anti-Iba1 (1:500; #019-19741,
Wako), mouse anti-SMI312 (1:500, smi-312r, Covance),
rabbit anti-p65 (1:100; sc-372, Santa Cruz; or #3033, Cell
Signaling). Stainings were visualised using secondary anti-
bodies from goat conjugated with Alexa Fluor 488, 596 or
647 (1:1000; Invitrogen; 2 h at room temperature). Nuclei
were stained with Hoechst 33258 (1:1000; Invitrogen).
Omission of primary antibodies served as negative con-
trols. Confocal images were acquired using a confocal
laser scanning microscope (LSM 700; Zeiss).
Cytokine and NF-kB quantification
Mice were sacrificed, and the corpus callosum was dis-
sected and stored in liquid nitrogen. Samples were homo-
genised in PBS containing protease/phosphatase inhibitor
(Thermo Scientific) using a Precellys 24 homogeniser
(Peqlab), and lysed in RIPA buffer (25 mM TRIS, 150 mM
NaCl, 1 % NP-40, 0.5 % Na-deoxycholate, 0.1 % SDS,
pH 7.2). Quantitative cytokine determination was
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performed using an electrochemiluminescence ELISA
(Mouse ProInflammatory Ultra-Sensitive Kit, Meso Scale
Discovery). Signals were measured on a SECTOR Imager
2400 reader (Meso Scale Discovery). For NF-kB measure-
ments, nuclear extracts were created from whole brain ho-
mogenates (Nuclear Extraction Kit, #2900, Millipore), and
NF-kB activity in nuclear extracts was determined with
a commercial assay (EZ-TFA assay, #70-610, Millipore)
according to the manufacturer’s instructions using a
microplate reader (FLUOstar Omega, BMG Labtech).
All measurements were performed in duplicates.
Behavioural tests
Male GFAP-IkBα-dn and wildtype mice have similar
phenotypes in behavioural paradigms, including spatial
learning and memory [18]. All tests were recorded and
analysed using Ethovision XT9 (Noldus). The Y maze
consisted of three arms (length, 34.5 cm; width, 8 cm;
height, 12.5 cm) extruding at equal angles from a central
platform. The Y Maze test was modified from previous
designs [19]. During the acquisition trial, one arm was
closed and mice were placed at the end of an open arm
(chosen at random) and allowed to explore the two open
arms for 5 min. After 24 h, mice were returned to the
maze with all 3 arms open; the start point corresponding
to the individual start point of each mouse in the acquisi-
tion trial, and allowed to explore for 5 min. Arm prefer-
ence was quantified as the ratio between the time spent in
one arm and the time spent in all arms (preferency index).
For open field exploration, mice were placed in the centre
of a dimly lit (20–30 lx) arena. The area was virtually
divided into a centre and an area ≤5 cm to the walls (sur-
round). General locomotor activity was quantified as total
distance moved and velocity. The level of anxiety was esti-
mated by the percentage of time spent in the surround.
Data analysis
Immunohistochemical images were imported into ImageJ
1.50 (W. Rasband, NIH), smoothed and despeckled using
a median filter, and converted to an 8-bit grey level image.
Following contrast enhancement (0.4 % saturated pixels),
images were binarised with a threshold defined as the
mean background intensity plus the standard deviation of
background intensity multiplied by 3. Astrocyte area
coverage and diameter, and micoglial cell count were de-
termined automatically by ImageJ. For astrocyte process
length, binarised images were skeletonised and analysed
using the Analyze Skeleton (2D/3D) plugin for ImageJ.
These semi-automatic quantifications were compared
with a subset of data (n = 3 from each group) that was
quantified by manual analysis; no significant difference
was detected between the analysis methods (data not
shown). GFAP-positive astrocytes were considered posi-
tive for p65 when they showed a spherical somatic p65
staining that was smaller than the GFAP-positive cell
soma and overlapped with the Hoechst 33258 nuclear
counterstain. Mean pixel intensity of SMI312 staining in
8-bit grey level images was taken as a measure of axonal
integrity. Demyelination was analysed in LFB-stained sec-
tions using a semi-quantitative scoring system (0 = no de-
myelination; 1 = visible fiber disarrangement; 2 = vacuoles
and focal demyelination; 3 = widespread/continuous de-
myelination). Examples are provided in Additional file 1:
Figure S1. Analysis of the corpus callosum was performed
within pre-defined areas (0.75 mm and 2.0 mm from the
midline). All measurements were taken in triplicates, and
the values averaged. Laser speckle contrast data were
down-sampled, exported into Excel (Microsoft), and nor-
malised to perfusion levels before microcoil implantation.
Paravision 5.1 (Bruker) was used to generate the para-
metric images used for white matter analysis. Fractional
anisotropy (FA), apparent diffusion coefficient (ADC),
axial diffusivity (AD) and radial diffusivity (RD) were
measured. Direction-encoded colour (DEC) maps based
on the primary eigenvectors were generated using in-
house software. The colour determines the principal dir-
ection (X, Y or Z) of the primary eigenvector exhibiting
the largest diffusion coefficient from the measured diffu-
sion tensor: red designates medial to lateral orientation,
blue represents dorsal to ventral orientation and green ex-
hibits the rostral to caudal orientation. Regions of interest
(ROIs) including the corpus callosum, external capsule
and internal capsule were manually drawn onto the diffu-
sion tensor images, and verified by comparison with the
corresponding T2-w image and a stereotaxic mouse brain
atlas [20]. Heatmaps were generated by a) registering the
FA images to a reference image within the respective co-
hort and b) setting landmarks on trace-weighted diffusion
images and transferring them onto their respective FA
images. Registration was performed using the bUnwarp
plugin (version 2.6.3) for ImageJ.
Statistical analysis
Comparisons between two groups were conducted using
the Mann–Whitney test. Differences between several
groups were analysed using the Kruskal-Wallis test
followed by Dunn’s multiple comparisons test. Data were
analysed using Prism 6 (GraphPad), and are expressed
as mean ± SEM; p < 0.05 was accepted as statistically
significant.
Results
Gliosis, demyelination, axonal loss and memory deficits
in a mouse model of VCI
We modified a model of bilateral common carotid artery
stenosis (BCAS) [13] by placing microcoils around both
common carotid arteries to induce chronic cerebral hy-
poperfusion in mice (Fig. 1a). Longitudinal laser speckle
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imaging demonstrated a reduction in cerebral blood flow
by 32 ± 9 % 24 h and 29 ± 8 % 7 days following BCAS
induction, respectively, whereas blood flow remained
unaltered in sham-treated mice (Fig. 1b-c). Separate
cohorts of mice, perfused either 1 week or 6 weeks after
BCAS induction, exhibited white matter demyelination
(Fig. 1d), reactive astrogliosis (Fig. 1e-g), microglial acti-
vation (Fig. 1h), and delayed degradation of white matter
axonal integrity (Fig. 1i). Reactive astrogliosis was evi-
dent by increased area coverage, cell size and process
length, although the latter parameter is also influenced
by GFAP redistribution induced by astrogliosis [12]. The
number of GFAP-positive astrocytes in the corpus
callosum did not differ between the groups, owing to the
high fraction of GFAP-positive astrocytes already present
in the white matter (148 ± 12/mm2 and 159 ± 10/mm2,
respectively; n = 6 for each group; p > 0.05, Mann–Whitney
test). No difference was seen in the number of NeuN-
positive neuronal cell bodies in the cortex (Sham, 1987 ±
211/mm2; BCAS, 2027 ± 274; n = 6 for each group;
p > 0.05, Mann–Whitney test). There was no change
in the rostro-caudal diameter of the corpus callosum,
measured in coronal sections, in mice subjected to
BCAS compared with sham-treated mice (211 ± 26 μm
vs. 201 ± 32 μm; n = 6 for each group; p > 0.05, Mann–
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Fig. 1 Chronic hyperperfusion induces demyelination, gliosis, axonal deterioration, and cognitive impairment. a Mice were subjected to bilateral
carotid artery stenosis (BCAS) by wrapping gold-plated microcoils (internal diameter, 170 μm) around the common carotid arteries. Scale bar,
3 mm. b Laser speckle contrast imaging of anaesthetised mice revealed long-lasting cerebral hypoperfusion after BCAS compared to sham-
treated mice (p < 0.05, Mann–Whitney test). c Representative examples of laser speckle contrast measurements of cerebral blood flow through
chronic cranial windows in mice subjected to BCAS or sham surgery before (Pre) and 7 d after the intervention. The look-up table represents
arbitrary perfusion units, indicating reduced blood flow after BCAS. d Luxol Fast Blue staining of the corpus callosum (0 = no demyelination; 1
= visible fiber disarrangement; 2 = vacuoles and focal demyelination; 3 = widespread/continuous demyelination) revealed demyelination 7 d
and 42 d after BCAS (n = 6 for each group; p < 0.05, Kruskal-Wallis test followed by Dunn’s multiple comparisons test). e-g The area cov-
ered by GFAP-positive astrocytes, astrocyte diameter and astrocyte process length were increased in mice subjected to BCAS in the corpus
callosum, indicating reactive astrogliosis (n = 6 for each group; p < 0.05, Mann–Whitney test). h Mild reactive microgliosis was also evident
6 weeks after BCAS, indicated by an increase in Iba1-positive cells (n = 6 for each group; p < 0.05, Mann–Whitney test). i In parallel, there was a
decrease in the density of SMI312-positive axons in the corpus callosum after 6 weeks, indicating axonal loss (n = 6 for each group; p < 0.05,
Mann–Whitney test). j Electrochemiluminescence measurements revealed an increase in the pro-inflammatory cytokines IL-1 and IL-6 in homoge-
nates from the corpus callosum (n = 8 for each group; p < 0.05, Mann–Whitney test)
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Additional file 2: Figure S2. Changes comparable to
those observed in the corpus callosum were detected in
the internal capsule and external capsule (Additional file
3: Figure S3).
Moreover, we found that the concentrations of the pro-
inflammatory cytokines, interleukin-1 and interleukin-6,
were increased in homogenates of the corpus callosum
isolated from mice subjected to BCAS (Fig. 1j).
To investigate spatial long-term memory, we used a
two-trial Y maze spatial memory task [19]. In the first
trial (acquisition), mice were allowed to visit two arms of
the maze, while the third arm was blocked. In the second
trial (retrieval) performed 24 h later, mice had access to all
three arms. As expected, given the natural tendency of
rodents to explore new environments, sham-treated mice
showed a strong preference for the novel arm in the
retrieval trial (Fig. 2a-b). By contrast, mice subjected to
BCAS showed no preference for the novel arm (Fig. 2b),
indicating decreased spatial memory function. Spontan-
eous locomotor activity and the level of anxiety, which
were investigated in the open field test, did not differ
between the groups (Fig. 2c-e) indicating that the deficits
of hypoperfused mice in the Y maze test were due to
impaired memory function and not to a decline in motor
function or general behavioural alterations.
NF-kB is activated by chronic hypoperfusion in reactive
white matter astrocytes
One consequence of the expression of pro-inflammatory
cytokines such as IL-1 is the activation of the nuclear
factor (NF)-kB signaling cascade in reactive astrocytes
[21]. Under control conditions, inactive NF-kB is local-
ised to the cytoplasm by its interaction with inhibitory
IkB proteins such as IkBα. Dissociation from IkB and
subsequent nuclear translocation of NF-kB is initiated
by the degradation of IkB through cytokine-induced IkB
kinase activation [22]. Once activated, NF-kB acts as an
important regulator of reactive gliosis, inflammation,
myelination and neuronal survival in different disease
models [12, 14, 23].
Therefore, we investigated the occurrence of activated
nuclear NF-kB by immunohistochemistry against the ac-
tive p65 (RelA) subunit of NF-kB. We found that 27.2 ±
7.1 % of all GFAP-positive white matter reactive astro-
cytes in hypoperfused mice were positive for nuclear (i.e.
active) p65 (n = 7 mice; Fig. 3a). By contrast, only sparse
and cytosolic (i.e. inactive) p65 labeling was visible in as-
trocytes from sham-treated mice (3.8 ± 1.8 %, n = 6 mice;
Fig. 3b). White matter microglia and neurons were only
very rarely positive for nuclear p65 in chronic hypoxic









































































































Fig. 2 Chronic hypoperfusion induces a decline in spatial long-term memory. a Representative example of spatial memory determination in the Y
Maze test. During the acquisition trial, arm 2 is closed, and the mouse moves freely between arms 1 and 3. 24 h later, in the retrieval trial, arm 2
is opened. The mouse showed a strong preference for this novel arm, indicated by longer cumulative duration and more arm entries (AE). b
Sham-treated mice spent significantly more time in the novel arm (n = 12; p < 0.05, Kruskal-Wallis test followed by Dunn’s multiple comparisons
test) whereas mice subjected to BCAS spent equal times in all arms, indicating spatial memory impairment (n = 12; p > 0.05, Kruskal-Wallis test
followed by Dunn’s multiple comparisons test). c-e The distance travelled and velocity of wildtype mice subjected to sham surgery or BCAS did
not differ significantly. The percentage of time spent in the surround (i. e. ≤5 cm to the wall of the arena), indicative of the level of anxiety, was
also similar (n = 12 for each group; Mann–Whitney test)
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0.3 % of NeuN-positive neurons, respectively). Hoechst-
positive and GFAP-negative punctuate p65 signals were
rare (7.3 ± 2.4 % of all Hoechst-positive p65 signals).
These data indicate that the majority of white matter
NF-kB activation in our model occurs in astrocytes. To
quantify NF-kB activity, we used a chemiluminescent
assay measuring the amount of p65 bound to the
flanked DNA binding consensus sequence for NF-kB in
nuclear extracts from brain homogenates. Consistent
with the immunohistochemistry, this assay demon-
strated strong NF-kB activation in the brains of mice
subjected to BCAS compared with sham (Fig. 3c).
These data indicate that reactive astrogliosis and chronic
inflammation of the white matter in hypoperfused mice
induces NF-kB activation in reactive astrocytes.
Astrocyte-specific transgenic inhibition of NF-kB activity
confers protection against structural and cognitive
decline following chronic hypoperfusion
To investigate the consequences of astroglial NF-kB acti-
vation, we used transgenic GFAP-IkBα-dn mice in which
astroglial NF-kB activation is selectively inhibited by tar-
geting the overexpression of a dominant negative form
of IkBα to astrocytes [14]. Earlier studies have shown
that the transgene is selectively active in astrocytes,
while NF-kB activity remains unchanged in neurons
[14]. Following BCAS, we found that nuclear p65 was
absent from reactive white matter astrocytes (Fig. 3d)
and that NF-kB activity was similar to sham-treated
mice (Fig. 3c).
The level and time course of cerebral blood flow
reduction (Fig. 4a) and the plasticity of the posterior
communicating artery (PcomA; Fig. 4b) were similar in
GFAP-IkBα-dn and wildtype mice (Laser speckle blood
flow levels from each individual day of measurement
were compared between GFAP-IkBα-dn and wildtype
mice; p > 0.05 for each comparison, Mann–Whitney test).
Thus, differences between these groups are unlikely to
be due to variability in the degree of hypoperfusion or
collateralisation between the anterior and posterior
cerebral artery circulation.
Interestingly, astrogliosis was detectable in GFAP-
IkBα-dn mice following BCAS but reactive microglial
activation and demyelination in white matter structures
were significantly attenuated (Fig. 4c-e). Furthermore,
axonal integrity within the corpus callosum was pre-
served in GFAP-IkBα-dn mice compared with sham-
treated controls (Fig. 4f ). Importantly, GFAP-IkBα-dn
mice subjected to hypoperfusion spent significantly more
time in the novel arm in the retrieval trial of the Y maze
test (Fig. 4g), indicating preserved spatial memory func-
tion as a consequence of decreased NF-kB signaling.
The open field test revealed no differences in distance
moved, velocity or time spent in the surround between
hypoperfused GFAP-IkBα-dn, sham-treated GFAP-IkBα-
dn and wildtype mice (Fig. 4h-j). Overall, these data
show that NF-kB activation in reactive astrocytes con-
tributes to neuropathological damage and behavioural
changes in our VaD model.
Ultra high-field diffusion tensor imaging reveals
preserved structural integrity of white matter tracts in
GFAP-IkBα-dn mice following BCAS
Magnetic resonance diffusion tensor imaging (DTI) is a
key technology that enables the non-invasive study of
structural connectivity of white matter tracts, and is an


































Fig. 3 Activation of the NF-kB pathway in reactive white matter
astrocytes during chronic hypoperfusion. a Reactive GFAP-positive
astrocytes (green) in the corpus callosum of mice subjected to BCAS
are positive for the active p65 (RelA) subunit of NF-kB (red). p65 was
localised to astroglial nuclei (arrows), indicated by co-localisation
with the nuclear marker Hoechst 33258 (blue). b Astrocytes were
rarely positive for p65 in sham-treated mice, and the signal was
diffuse and localised to the cytosol (arrowheads), indicating non-
activity. c Biochemical determination of NF-kB activity in brain
homogenates showed strong activation of the NF-kB pathway in
wildtype mice subjected to BCAS but not in GFAP-IkBα-dn mice
subjected to BCAS or sham-treated wildtype mice (n = 6 for each
group; Kruskal-Wallis test followed by Dunn’s multiple comparisons
test). d Within the corpus callosum of GFAP-IkBα-dn mice subjected
to BCAS, immunohistochemistry for active p65 was also negative.
Scale bars, 100 μm. Insets in A-B correspond to dashed squares
and are 80 μm in width. Yellow dashed lines indicate location of
the corpus callosum
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of patients with vascular dementia [24, 25]. Therefore,
we investigated whether the preservation of axonal in-
tegrity observed in GFAP-IkBα-dn mice was detectable
by DTI MRI. DTI was performed on hypoperfused or
sham-treated wildtype and GFAP-IkBα-dn mice 6 weeks
post surgery. Coronal images from brain areas encom-
passing the major white matter tracts (corpus callosum,
internal capsule and external capsule) were acquired,
and fractional anisotropy (FA), apparent diffusion co-
efficient (ADC), axial (AD) and radial diffusivity (RD)
were measured. Representative direction-encoded colour
(DEC) maps are shown in Fig. 5a. We detected signifi-
cant changes in white matter FA, ADC, AD and RD
values in wildtype mice subjected to BCAS compared
with sham-treated mice (Fig. 5b-e and Additional file 4:
Figure S4). This indicates that hypoperfusion induced
deterioration in white matter integrity consistent with
the observed histopathological changes. By contrast,
GFAP-IkBα-dn mice subjected to BCAS mice did not
exhibit a difference in the diffusivity measures when
compared with sham-treated GFAP-IkBα-dn mice, under-
lining the strong attenuation in pathology compared with
wildtype animals (Fig. 5b-e). T1- and T2-weighted imaging
revealed no signs of overt anatomical damage in any
group (Additional file 5: Figure S5).
Discussion
In this study, we investigated the role of the pro-
inflammatory NF-kB pathway in reactive astroglia in a
mouse model of vascular cognitive impairment and found
that transgenic inhibition of NF-kB signaling confers pro-
tection from axonal loss, gliosis, demyelination, deterior-
ation of white matter integrity and memory impairment.
Although vascular cognitive impairment is associated
with an enormous clinical and socioeconomic burden,
causal treatment options are absent, mostly because the
molecular pathways triggered by chronic cerebral hypo-
perfusion remain poorly understood. Importantly, clin-
ical and experimental studies have shown that vascular
impairment is associated with inflammatory changes and
a b c
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Fig. 4 GFAP-IkBα-dn mice are protected from the deleterious effects of chronic hypoperfusion. a Laser speckle contrast imaging of GFAP-IkBα-dn
mice demonstrated cerebral hypoperfusion after BCAS compared with sham-treated mice (p < 0.05, Mann–Whitney test) similar to blood flow
levels observed in wildtype mice shown in Fig. 1. b India ink angiograms revealed that the patency/development of the posterior communicating
artery (PComA) was similar in wildtype and GFAP-IkBα-dn mice (n = 5 for each group; p > 0.05, Mann–Whitney test). c-f Reactive astrogliosis was
evident in GFAP-IkBα-dn mice after BCAS. However, microgliosis, demyelination and loss of axonal integrity were strongly ameliorated (6 weeks
after BCAS; n = 6 for each group and staining; Mann–Whitney test for each comparison). g 6 weeks after BCAS, GFAP-IkBα-dn mice spent significantly
more time in the novel arm during the retrieval trial of the Y maze compared to wildtype mice subjected to BCAS, indicating preserved spatial memory
function (n = 12 for each group; Mann–Whitney test; Two-way ANOVA: F(1, 46) = 5.52, p = 0.02 for genotype effect). h-j The distance travelled and
velocity, as well as the level of anxiety, of GFAP-IkBα-dn mice subjected to sham surgery or BCAS did not differ significantly and was similar to
wildtype mice. Wildtype mouse data in G-J correspond to those in Fig. 2
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reactive gliosis of the white matter [4–7, 9], indicating
that white matter damage is not simply a consequence
of chronic oxygen deprivation but is induced and sus-
tained by a pro-inflammatory environment. The hall-
marks of chronic inflammation:reactive gliosis of white
matter astrocytes and microglia, and expression of pro-
inflammatory cytokines, were also detected in our
model and associated with axonal degeneration, demye-
lination, spatial memory impairment and loss of white
matter integrity. Importantly, the DTI signatures of
hypoperfused mice corroborated with the demyelin-
ation and axonal degeneration observed on histology
[26], and were comparable to those observed in clinical
vascular cognitive impairment [27]. The cellular
sources of IL-1 and IL-6 are difficult to define in vivo
using our model. However, earlier studies have shown
that microglia and, to a lesser degree, astrocytes release
these cytokines during hypoxia [1, 23, 28]. Hence, both
cell types may induce and sustain the pro-inflammatory
environment that ultimately leads to demyelination.
Moreover, progressive demyelination may further ex-
acerbate gliosis [28].
Reactive astrogliosis is a pervasive but insufficiently
understood response mechanism of the brain to acute or
chronic injury [12]. Interestingly, we found that astro-
gliosis induces activation of the pro-inflammatory NF-kB
pathway, and that transgenic inhibition of NF-kB signal-
ing in reactive astrocytes confers protection from neuro-
degeneration and cognitive impairment. Notably, some
degree of gliosis was evident in transgenic mice after
BCAS, indicating that multiple pathways may be involved
[12]. The protective effect of NF-kB on white matter in-
tegrity was also detectable using DTI, underlining the sig-
nificance of DTI as a longitudinal marker of treatment
response in future translational studies.
It should be noted that the model used in the present
study, and arguably in previously published animal stud-
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WT BCASWT sham IκBα-dn BCASIκBα-dn Sham
Fig. 5 Ultra high-field diffusion tensor imaging reveals preserved
structural integrity of major white matter tracts in GFAP-IkBα-dn
mice. a Anaesthetised wildtype or GFAP-IkBα-dn mice, either sham-
treated or subjected to BCAS, were imaged using ultra high-field DTI
MRI. Major white matter tracts (CC, corpus callosum; IC, internal
capsule; EC, external capsule) were identified in direction-encoded
colour (DEC) images (red, medial to lateral orientation; blue, dorsal
to ventral orientation; green, rostral to caudal orientation) based
on the primary eigenvectors. b Fractional anisotropy was significantly
decreased in all regions of interest in wildtype but not in GFAP-IkBα-dn
mice subjected to BCAS. c BCAS induced significant changes in the
apparent diffusion coefficient (ADC) of the internal capsule and
external capsule in wildtype but not in GFAP-IkBα-dn mice. d-e Axial
and radial diffusivity were also significantly altered in wildtype but
not in GFAP-IkBα-dn mice subjected to BCAS (wildtype sham, n = 6;
wildtype BCAS, n = 5; GFAP-IkBα-dn sham, n = 3; GFAP-IkBα-dn BCAS,
n = 5; Mann–Whitney test for all comparisons)
Saggu et al. Acta Neuropathologica Communications  (2016) 4:76 Page 8 of 10
vascular cognitive impairment including the chronic
evolution of the disease over decades, the predominant
affection of small vessels, and cardiovascular and envir-
onmental co-morbidities. Therefore, an important
question for future studies is whether the protective ef-
fect of NF-kB inhibition is evident in models that re-
capitulate other aspects of human vascular cognitive
impairment. One other important point to address will
be whether astroglial NF-kB contributes to pathways
such as those mediated by hypoxia-inducible transcription
factor-1 activation or perturbed glutamate uptake [29, 30]
in models of vascular cognitive impairment. Furthermore,
as NF-kB pathway inhibitors progress through pre-clinical
development [31], it will be of great interest to investigate
whether these compounds confer comparable protec-
tion from chronic hypoxia.
The NF-kB pathway has been implicated in other
pathological conditions such as autoimmune or toxic
demyelination and spinal cord injury [14, 23, 32]. Here,
we demonstrated that activation of NF-kB in astrocytes
contributes not only to white matter demyelination and
axonal loss during chronic hypoxia but that an astro-
cytic pro-inflammatory pathway may have important
consequences for cognitive outcome in neurodegenera-
tive disease.
Conclusions
Our study has demonstrated that chronic activation and
gliosis of astrocytes are central components of disease
pathogenesis in a model of vascular cognitive impairment,
and that therapeutic strategies targeting these pathways
may lead to novel treatment options for vascular dementia.
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Additional file 1: Figure S1. Scoring system to measure demyelination.
Representative LFB stainings from the corpus callosum and the
corresponding grades are provided. (PDF 2173 kb)
Additional file 2: Figure S2. Histological and immunohistochemical
changes induced by BCAS. The corpus callosum is delineated by yellow
dashed lines in all images. (A) Luxol Fast Blue (LFB) staining of the corpus
callosum in sham-treated mice and mice subjected to BCAS revealed
fibre disarrangement, vacuoles and focal demyelination following BCAS.
(B) Astrocytes, stained by an anti-GFAP antibody, became reactive, as
indicated by higher area coverage, larger cell diameters, and longer
processes. (C) The number of Iba1-positive microglia increased within
the corpus callosum. (D) The signal intensity of axons stained with the
pan-axonal marker SMI312 decreased after BCAS, indicative of axonal
damage. (E) The number of NeuN-positive neuronal cell bodies was
comparable in both groups. Scale bars, 100 μm. (PDF 7114 kb)
Additional file 3: Figure S3. Histological changes in the internal and
external capsule. Reactive astrogliosis (A, E), microgliosis (B, F), axonal
degeneration (C, G) and demyelination (D, H) in sham and BCAS animals in
the internal capsule (upper row) and external capsule (lower row). (PDF 118 kb)
Additional file 4: Figure S4. Fractional anisotropy maps. Representative
examples of fractional anisotropy maps in two coronal imaging planes
(relative to Bregma) in wildtype or GFAP-IkBα-dn mice subjected to BCAS
or sham surgery, respectively. (PDF 6689 kb)
Additional file 5: Figure S5. T1- and T2-weighted images show no
changes following BCAS. Representative examples of T1- and T2-weighted
coronal images in wildtype or GFAP-IkBα-dn mice subjected to BCAS or
sham surgery, respectively. These images show that grey and white matter
structures are devoid of pathological signal changes. (PDF 2360 kb)
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